Book Review - From Need to Price and Back Again? Excavating the Myth of Affordable Housing by Quintin Bradley, 2026
Radical Housing Journal · 16.11.2026 · 8 (2) · 241-245
DOI: 10.54825/gpwe8609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radical Housing Journal, online erschienen am 16.11.2026. Verfasst von Neil Gray.
Abstract (Originalsprache)
Quintin Bradley’s The Myth of Affordable Housing moves the debate on public housing considerably. That ‘affordable housing’ is a specious category will be no surprise to many RHJ readers. But Bradley provides not only a remarkably detailed critique of the semiotic damage done to the term by successive neoliberal governments and housing policy wonks, he also, more fundamentally, supersedes narrow policy critique to refute the very presuppositions of the economic principles this charade masks. The signature theoretical contribution of the book is an exacting critique of the subordination of ‘need’ to ‘price’ within the ‘affordable housing’ category, subverting mainstream policy orthodoxy (and the arguments of many progressive housing professionals) by arguing that the purpose of ‘affordable housing’ as a niche commodity in the housing market is not to reduce home prices but to uphold them. This understanding poses crucial questions about the nature of credible demands for low-cost socialised homes.
Zitieren
APA
Gray, N. (2026). Book Review - From Need to Price and Back Again? Excavating the Myth of Affordable Housing by Quintin Bradley, 2026. Radical Housing Journal, 8(2), 241-245. https://doi.org/10.54825/gpwe8609
Vancouver
Gray N. Book Review - From Need to Price and Back Again? Excavating the Myth of Affordable Housing by Quintin Bradley, 2026. Radical Housing Journal. 2026;8(2):241-245. doi:10.54825/gpwe8609
BibTeX
@article{Gray2026,
author = {Gray, Neil},
title = {Book Review - From Need to Price and Back Again? Excavating the Myth of Affordable Housing by Quintin Bradley, 2026},
journal = {Radical Housing Journal},
year = {2026},
volume = {8},
number = {2},
pages = {241--245},
doi = {10.54825/gpwe8609}
}
EUVIMED